News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Luis Diaz: Congratulations to Andrea Cercek for being named to the inaugural 2024 TIME100 Health
Photo collage of Luis Diaz & Andrea Cercek taken from LinkedIn
May 2, 2024, 23:18

Luis Diaz: Congratulations to Andrea Cercek for being named to the inaugural 2024 TIME100 Health

Luis Diaz, Head of Division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center, shared on LinkedIn:

“Congratulations to Andrea Cercek from Memorial Sloan Kettering Cancer Center for being named to the inaugural 2024 TIME100 Health, a new annual list of 100 individuals who most influenced global health this year.”

Additional information.
Source: Luis Diaz/LinkedIn
OncoDaily

Andrea Cercek cancer Cancer Center Cancer research global health Global Health Influencers health advocacy Health Impact Health Influencers Health Leaders Healthcare Awards Healthcare Excellence Healthcare Influencer Healthcare Influencers Healthcare Recognition Luis Diaz Medical Achievements Medical Innovation Medical Recognition Memorial Sloan Kettering Cancer Center OncoDaily Oncology TIME100 Health TIME100 Health 2024
Special Coverage
Blog
May 9, 2025, 09:29
ESO - M2ICOS Project Launches Fellowship Program to Support Oncology Training and Mobility in the EU
Science
May 9, 2025, 09:22
Myeloma Paper of the Day, May 9th, suggested by Robert Orlowski
Drugs
May 9, 2025, 09:15
Penpulimab: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Drugs
May 9, 2025, 08:47
Jonathan Pachter: FDA Grants Accelerated Approval for 1st Targeted Therapy in KRAS-Mutant LGSOC
Blog
May 9, 2025, 08:15
Parminder Singh: Grand Rounds at Mayo Clinic
Science
May 9, 2025, 08:02
Ashish Kamat: Predictive Value of AI Histologic Biomarker CHAI in NMIBC Treatment
Drugs
May 9, 2025, 07:54
Rahul Banerjee: Financial Toxicity Is the First Side Effect of Lenalidomide in Multiple Myeloma
Blog
May 9, 2025, 07:41
Eric Singhi: First-Year Fellow’s Graduation from the Singhi Clinic
Science
May 9, 2025, 07:24
Elizabeth McKenna: Study on Early- and Older-Onset Cancer Trends in the U.S. by Meredith Shiels and colleagues
Drugs
May 9, 2025, 07:19
Jenny Seligmann: FOxTROT 5 Opens in the UK – New immunotherapy trial for older colon cancer patients
Career
May 9, 2025, 07:02
Vinay Prasad Appointed as the New Head of FDA's Center for Biologics Evaluation and Research
Blog
May 9, 2025, 06:47
Wade Swenson: Addressing the rural cancer care crisis in Minnesota requires innovative solutions